Get the Stockscreener App
1.49
4.49%
-0.07
After Hours:
1.49
Zentalis Pharmaceuticals Inc stock is traded at $1.49, with a volume of 505.46K.
It is down -4.49% in the last 24 hours and up +5.67% over the past month.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
See More
Previous Close:
$1.56
Open:
$1.54
24h Volume:
505.46K
Relative Volume:
0.56
Market Cap:
$107.48M
Revenue:
-
Net Income/Loss:
$-292.19M
P/E Ratio:
-0.3282
EPS:
-4.54
Net Cash Flow:
$-208.41M
1W Performance:
-14.86%
1M Performance:
+5.67%
6M Performance:
-23.59%
1Y Performance:
-52.70%
1-Day Range:
$1.485
$1.5796
1-Week Range:
$1.46
$1.75
52-Week Range:
$1.01
$5.44
Zentalis Pharmaceuticals Inc Stock (ZNTL) Company Profile
Name
Zentalis Pharmaceuticals Inc
Sector
Industry
Phone
(858) 263-4333
Address
10275 SCIENCE CENTER DRIVE, SAN DIEGO, NY
Compare ZNTL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZNTL
Zentalis Pharmaceuticals Inc
|
1.49 | 105.32M | 0 | -292.19M | -208.41M | -4.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Zentalis Pharmaceuticals Inc Stock (ZNTL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-12-24 | Upgrade | Wedbush | Underperform → Neutral |
| Jun-20-24 | Downgrade | UBS | Buy → Neutral |
| Jun-18-24 | Downgrade | Jefferies | Buy → Hold |
| Jun-18-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-18-24 | Downgrade | Wedbush | Neutral → Underperform |
| Jun-18-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Nov-08-23 | Downgrade | Wedbush | Outperform → Neutral |
| Nov-07-23 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jul-12-22 | Initiated | Cowen | Outperform |
| Apr-06-22 | Initiated | Wells Fargo | Overweight |
| Oct-07-21 | Resumed | Jefferies | Buy |
| Sep-30-21 | Initiated | Stifel | Buy |
| Sep-29-21 | Initiated | Oppenheimer | Outperform |
| May-21-21 | Initiated | UBS | Buy |
| Jan-20-21 | Initiated | Wedbush | Outperform |
| Sep-29-20 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-27-20 | Initiated | H.C. Wainwright | Buy |
| Apr-28-20 | Initiated | Guggenheim | Buy |
| Apr-28-20 | Initiated | Jefferies | Buy |
| Apr-28-20 | Initiated | Morgan Stanley | Overweight |
| Apr-28-20 | Initiated | SVB Leerink | Outperform |
View All
Zentalis Pharmaceuticals Inc Stock (ZNTL) Latest News
Tick level data insight on Zentalis Pharmaceuticals Inc. volatilityJuly 2025 Setups & Fast Entry Momentum Trade Alerts - Newser
Applying Elliott Wave Theory to Zentalis Pharmaceuticals Inc.July 2025 Technicals & Verified Momentum Stock Watchlist - Newser
Risk adjusted return profile for Zentalis Pharmaceuticals Inc. analyzedJuly 2025 Levels & Low Risk Entry Point Guides - Newser
What to expect from Zentalis Pharmaceuticals Inc. in the next 30 daysBond Market & Growth-Oriented Investment Plans - Newser
Will Zentalis Pharmaceuticals Inc. stock recover after recent dropNew Guidance & Safe Entry Trade Reports - Newser
Is Zentalis Pharmaceuticals Inc. stock poised for growthMarket Movement Recap & Free Weekly Watchlist of Top Performers - Newser
Is a relief rally coming for Zentalis Pharmaceuticals Inc. holdersQuarterly Growth Report & Expert Approved Momentum Ideas - Newser
Heatmap analysis for Zentalis Pharmaceuticals Inc. and competitorsQuarterly Profit Summary & Expert Verified Movement Alerts - Newser
Analyzing Zentalis Pharmaceuticals Inc. with risk reward ratio chartsProduct Launch & Free Reliable Trade Execution Plans - Newser
why zentalis pharmaceuticals inc. is moving todayJuly 2025 Breakouts & AI Based Trade Execution Alerts - Newser
Using data tools to time your Zentalis Pharmaceuticals Inc. exitLong Setup & Weekly Setup with ROI Potential - Newser
Published on: 2025-09-12 01:11:30 - Newser
Exit strategy if you’re trapped in Zentalis Pharmaceuticals Inc.Portfolio Update Summary & Long-Term Safe Investment Plans - Newser
Advanced analytics toolkit walkthrough for Zentalis Pharmaceuticals Inc.Weekly Risk Summary & Fast Exit/Entry Strategy Plans - Newser
Tools to monitor Zentalis Pharmaceuticals Inc. recovery probability2025 Trading Recap & Daily Entry Point Trade Alerts - Newser
How to manage a losing position in Zentalis Pharmaceuticals Inc.Earnings Trend Report & Technical Buy Zone Confirmation - Newser
Will Zentalis Pharmaceuticals Inc. benefit from macro trendsM&A Rumor & Safe Entry Zone Identification - Newser
Using flow based indicators on Zentalis Pharmaceuticals Inc.Swing Trade & Real-Time Volume Triggers - Newser
Is Zentalis Pharmaceuticals Inc. reversing from oversold territory2025 Volume Leaders & Community Verified Watchlist Alerts - Newser
How to use a screener to detect Zentalis Pharmaceuticals Inc. breakoutsChart Signals & Safe Entry Momentum Tips - Newser
VIX Spike: Is Zentalis Pharmaceuticals Inc. likely to announce a buybackStop Loss & Expert Approved Trade Ideas - Lancaster City Council
Visualizing Zentalis Pharmaceuticals Inc. stock with heatmapsEarnings Miss & Fast Gain Stock Trading Tips - Newser
what makes zentalis pharmaceuticals inc. stock price move sharplyQuarterly Growth Report & Stock Timing and Entry Methods - Newser
Zentalis Pharmaceuticals Inc. Reaches Critical Trendline SupportJuly 2025 Movers & Target Return Focused Picks - beatles.ru
Zentalis Pharmaceuticals Inc. Shows Risk Reward Favoring Upside2025 Bull vs Bear & Risk Controlled Daily Trade Plans - beatles.ru
Nuveen LLC Buys New Holdings in Zentalis Pharmaceuticals, Inc. $ZNTL - MarketBeat
Custom watchlist performance reports with Zentalis Pharmaceuticals Inc.Market Volume Summary & Weekly Momentum Stock Picks - Newser
Understanding Zentalis Pharmaceuticals Inc.’s price movement2025 Market Outlook & Smart Swing Trading Alerts - Newser
How to use Fibonacci retracement on Zentalis Pharmaceuticals Inc.2025 Biggest Moves & AI Driven Stock Reports - Newser
Zentalis Pharmaceuticals Inc. stock momentum explainedJuly 2025 Fed Impact & Verified Momentum Watchlists - Newser
Aug PreEarnings: Is Zentalis Pharmaceuticals Inc. stock trending bullishJuly 2025 Update & Weekly High Return Opportunities - خودرو بانک
Is Zentalis Pharmaceuticals Inc. stock showing strong momentumFed Meeting & Free Fast Entry Momentum Trade Alerts - خودرو بانک
Will Zentalis Pharmaceuticals Inc. outperform during market ralliesInsider Buying & Momentum Based Trading Signals - خودرو بانک
Will Zentalis Pharmaceuticals Inc. stock recover after earningsTrade Signal Summary & Daily Entry Point Trade Alerts - خودرو بانک
Will Zentalis Pharmaceuticals Inc. benefit from AI trendsWeekly Trend Summary & Daily Technical Forecast Reports - خودرو بانک
What is the next catalyst for Zentalis Pharmaceuticals Inc.Trade Risk Summary & Verified Momentum Watchlists - خودرو بانک
Published on: 2025-09-05 14:44:43 - Newser
Breakouts Watch: Is Zentalis Pharmaceuticals Inc. stock showing strong momentumQuarterly Profit Report & Accurate Buy Signal Notifications - خودرو بانک
Zentalis Pharmaceuticals Inc. stock outlook for YEARJuly 2025 Catalysts & Safe Investment Capital Preservation Plans - Newser
Using Ichimoku Cloud for Zentalis Pharmaceuticals Inc. technicalsRate Cut & High Conviction Buy Zone Picks - Newser
Published on: 2025-09-04 22:09:09 - Newser
Why Zentalis Pharmaceuticals Inc. is moving today2025 Big Picture & Fast Gaining Stock Reports - Newser
Using portfolio simulators with Zentalis Pharmaceuticals Inc. includedEarnings Overview Report & Expert Approved Momentum Ideas - Newser
Zentalis Pharmaceuticals Inc Stock (ZNTL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):